Publication | Closed Access

High pre‐treatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small‐cell lung cancer

AngiogenesisPoor OutcomeMedicineHigh Pre‐treatmentPathologySmall‐cell Lung CancerCancer TreatmentVascular Endothelial Growth FactorOncologyRadiation OncologyLung CancerCancer ResearchCancer GrowthHealth Sciences